Your browser doesn't support javascript.
[Good practice for aerosol therapy by nebulization in 2020]. / Bonnes pratiques de l'aérosolthérapie par nébulisation en 2020.
Dubus, J-C; Becquemin, M-H; Vecellio, L; Chaumuzeau, J-P; Reychler, G.
  • Dubus JC; Pneumologie et allergologie pédiatrique, CHU Timone-Enfants, et Aix Marseille Université, IRD, MEPHI, IHU-Méditerranée Infection, Marseille, France. Electronic address: jean-christophe.dubus@ap-hm.fr.
  • Becquemin MH; Hôpitaux universitaires Pitié-Salpétrière-Charles Foix, AP-HP, Paris, France.
  • Vecellio L; Inserm, centre d'étude des pathologies respiratoires (CEPR), UMR 1100, université de Tours, Tours, France.
  • Chaumuzeau JP; Groupe aérosolthérapie, SPLF, Paris, France.
  • Reychler G; Service de pneumologie, université catholique de Louvain, cliniques universitaires Saint-Luc, et institut de recherche expérimentale et clinique, Bruxelles, Belgique.
Rev Mal Respir ; 38(2): 171-176, 2021 Feb.
Article in French | MEDLINE | ID: covidwho-956559
ABSTRACT
Nebulization is a drug delivery mode whose prescription and application remain uncertain. A guide to good practice has been proposed by the work group on aerosol therapy of the French Society for Respiratory Diseases, so-called GAT. The previous recommendations date from 2007. In addition to an update of data on nebulization, these expert recommendations aim to be of real help to the prescriber.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nebulizers and Vaporizers / Drug Delivery Systems Limits: Humans Language: French Journal: Rev Mal Respir Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nebulizers and Vaporizers / Drug Delivery Systems Limits: Humans Language: French Journal: Rev Mal Respir Year: 2021 Document Type: Article